The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America
Abstract
Objective.We designed a longitudinal clinical database for autosomal recessive polycystic kidney disease (ARPKD), recruited patients from pediatric nephrology centers in the United States and Canada, and examined their clinical morbidities and survival characteristics. We initially targeted enrollment to children who were born and diagnosed after January 1, 1990, so as to capture a cohort that is representative of ARPKD patients born in the last decade. When a significant number of older ARPKD patients were also referred, we extended our database to include all patients who met our inclusion criteria, thereby allowing direct comparisons between a long-term survivor subset and a cohort that included both neonatal survivors and nonsurvivors. Design.Patient entry into our database required either compatible histopathology or ultrasonographic evidence of enlarged, echogenic kidneys and the presence of at least 1 of the following additional criteria: a) biopsy-proven ARPKD in a sibling; b) biliary fibrosis based on either clinical or histopathologic evidence; c) no sonographic evidence of renal cysts in the parents (parents must be >30 years of age); or d) parental consanguinity, eg, first-cousin marriage. Clinical questionnaires (primary data form and follow-up data form) were developed to collect initial patient data and follow-up data at yearly intervals. Results.Thirty-four centers provided clinical information for 254 patients and of these, 209 had sufficient data for analyses. When stratified by date of birth, 166 (79.4%) were born on or after January 1, 1990 (younger cohort) and 43 children (20.6%) were born before 1990 (older cohort). The gender distribution was equal in both cohorts. The median age at diagnosis was significantly later in the older cohort and no deaths were reported among these patients, suggesting that this group is biased toward long-term survivors. In the younger cohort, 74.7% of the patients are alive, with a median age of 5.4 years. In this group, 40.5% of patients required ventilation and 11.6% developed chronic lung disease. Hypertension was a common, but not universal finding in both cohorts. The relative risk for developing hypertension was higher in the older cohort, but the median age at diagnosis was significantly earlier in the younger cohort. Chronic renal insufficiency (CRI) was reported in ∼40% of patients with no significant difference in the relative risk between age groups. However, in the younger cohort, the median age at diagnosis was significantly earlier and the age of diagnosis of CRI and hypertension were significantly correlated. Clinically significant morbidities related to periportal fibrosis were more common in the older cohort. There was a trend toward increasing frequency of portal hypertension with age in both cohorts. Portal hypertension was not significantly correlated with either systemic hypertension or CRI. Conclusions.The ARPKD Clinical Database represents the largest single cohort of ARPKD patients collected to date. Our initial data analysis provides several new clinical insights. First, in our subset of long-term survivors, ARPKD has a slower rate of disease progression, as assessed by age of ARPKD diagnosis, as well as age of diagnosis of clinical morbidities. Second, neonatal ventilation was strongly predictive of mortality as well as an earlier age of diagnosis in those who developed hypertension or chronic renal insufficiency. However, for infants who survive the perinatal period, the long-term prognosis for patient survival is much better than generally perceived. Third, although systemic hypertension and CRI were significantly correlated with respect to age of diagnosis, similar relationships with portal hypertension were not evident, suggesting that disease progression may have organ-specific patterns. Fourth, only a subset of patients may be at risk for developing clinically significant manifestations of periportal fibrosis. Based on these observations, the next challenges will be to determine how various factors, such as specific mutations in the ARPKD gene, PKHD1(polycystic kidney and hepatic disease 1), variations in modifying gene loci, modulation by as yet unspecified environmental factors, and/or gene-environment interactions contribute to the marked variability in survival and disease expression observed among ARPKD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schwartz, G. J., Haycock, G. B., Edelmann, C. M., & Spitzer, A. (1976) · Pediatrics · doi:10.1542/peds.58.2.259 · Cited by 2,379
Ward, C. J., Hogan, M. C., Rossetti, S., Walker, D., Sneddon, T., Wang, X., Kubly, V., Cunningham, J. M., Bacallao, R., Ishibashi, M., et al. (2002) · Nature Genetics · doi:10.1038/ng833 · Cited by 765
Onuchic, L. F., Furu, L., Nagasawa, Y., Hou, X., Eggermann, T., Ren, Z., Bergmann, C., Senderek, J., Esquivel, E., Zeltner, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340448 · Cited by 508
Self-citationA simple estimate of glomerular filtration ratein full-term infants during the first year of life
Schwartz, G. J., Feld, L. G., & Langford, D. J. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80479-5 · Cited by 465
Zerres, K., M�cher, G., Becker, J., Steinkamm, C., Rudnik-Sch�neborn, S., Heikkil�, P., Rapola, J., Salonen, R., Germino, G. G., Onuchic, L., et al. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980305)76:2<137::aid-ajmg6>3.0.co;2-q · Cited by 263
Self-citationAutosomal recessive polycystic kidney disease
Kaplan, B. S., Fay, J., Shah, V., Dillon, M. J., & Martin Barratt, T. (1989) · Pediatric Nephrology · doi:10.1007/bf00859625 · Cited by 247
Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors
Roy, S., Dillon, M. J., Trompeter, R. S., & Barratt, T. M. (1997) · Pediatric Nephrology · doi:10.1007/s004670050281 · Cited by 213
Proteinuria and blood pressure as causal components of progression to end-stage renal failure
Locatelli, F., Marcelli, D., Comelli, M., Alberti, D., Graziani, G., Buccianti, G., Redaelli, B., Giangrande, A., & Italy the Northern Italian Cooperative Study Group (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.3.461 · Cited by 191
Hypertension in autosomal dominant polycystic kidney disease
Bell, P. E., Hossack, K. F., Gabow, P. A., Durr, J. A., Johnson, A. M., & Schrier, R. W. (1988) · Kidney International · doi:10.1038/ki.1988.233 · Cited by 172
Polycystic kidney disease in the first year of life
Cole, B. R., Conley, S. B., & Stapleton, F. B. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80244-5 · Cited by 162
Cited by
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationHarris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Bergmann, C., Senderek, J., Windelen, E., Küpper, F., Middeldorf, I., Schneider, F., Dornia, C., Rudnik-Schöneborn, S., Konrad, M., Schmitt, C. P., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00148.x · Cited by 348
Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases
Torres, V. E., & Harris, P. C. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0070 · Cited by 296
Hypertension in infancy: diagnosis, management and outcome
Dionne, J. M., Abitbol, C. L., & Flynn, J. T. (2012) · Pediatric Nephrology · doi:10.1007/s00467-010-1755-z · Cited by 275
Metadata
- Authors
- Guay-Woodford, L. M., & Desmond, R. A.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2003-05-01
- Volume
- 111
- Issue
- 5
- Pages
- 1072-1080
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2061060689
- Cited by
- 426
- References
- 10
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America. https://app.cochat.ai/papers/10.1542/peds.111.5.1072
- The paper
- Guay-Woodford, L. M., & Desmond, R. A. (2003). Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America. Pediatrics. https://doi.org/10.1542/peds.111.5.1072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.